Suppr超能文献

比较原发性肢体软组织肉瘤术后常规放疗与调强放疗。

Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.

机构信息

St. Luke's Cancer Centre, Royal Surrey County Hospital, Surrey, UK.

出版信息

Radiother Oncol. 2009 Oct;93(1):125-30. doi: 10.1016/j.radonc.2009.06.010. Epub 2009 Jul 13.

Abstract

INTRODUCTION

Doses in conventional radiotherapy for extremity soft tissue sarcoma (STS) potentially exceed normal tissue tolerances. This study compares 3D-conformal radiotherapy (3D-CRT) with intensity-modulated radiotherapy (IMRT) in optimising target volume coverage and minimising integral dose to organs-at-risk (OAR).

METHODS AND MATERIALS

Ten patients undergoing post-operative radiotherapy for extremity STS were assessed. PTV(1) was defined as tumour bed plus 5cm superiorly/inferiorly and 3cm circumferentially, PTV(2) was defined as 2cm isotropically. OAR were defined as whole femur, neurovascular bundle, tissue corridor and normal tissue outside PTV(1). For each patient 2-phase 3D-CRT was compared to 2/3 field (2/3f) and 4/5 field (4/5f) IMRT with simultaneous integrated boost (SIB). The primary planning objective was to minimise femur and skin corridor dose. Volumetric analysis and conformity and heterogeneity indices were used for plan comparison.

RESULTS

A planning protocol containing dose/volume constraints for target and OAR was defined. 4/5f IMRT showed greatest conformity and homogeneity. IMRT resulted in significantly lower femur V45 using 2/3f (p=0.01) and 4/5f (p=0.0009) than 3D-CRT. 4/5f IMRT resulted in significantly lower normal tissue V55 (p=0.004) and maximum dose (p=0.04) than 3D-CRT.

CONCLUSIONS

A reproducible set of planning guidelines and dose-volume constraints for 3D-CRT and IMRT planning for extremity sarcomas was devised. 4/5f IMRT with SIB resulted in better target coverage and significantly decreased OAR dose. Further evaluation of this technique within a clinical trial is recommended to demonstrate that the technical benefit of the more complex technique translates into patient-derived benefit by reducing late toxicity.

摘要

介绍

在治疗肢体软组织肉瘤(STS)时,传统放疗的剂量可能超过正常组织的耐受量。本研究通过比较三维适形放疗(3D-CRT)和调强放疗(IMRT),旨在优化靶区覆盖范围并降低危及器官(OAR)的积分剂量。

方法与材料

对 10 例接受肢体 STS 术后放疗的患者进行评估。PTV(1)定义为肿瘤床加 5cm 上下和 3cm 周向,PTV(2)定义为 2cm 各向同性。OAR 定义为整个股骨、血管神经束、组织通道和 PTV(1)外的正常组织。对于每位患者,比较了两阶段 3D-CRT 与 2/3 野(2/3f)和 4/5 野(4/5f)调强放疗同步整合增敏(SIB)。主要的计划目标是尽量降低股骨和皮肤通道的剂量。使用容积分析、适形度和不均匀性指数进行计划比较。

结果

定义了包含靶区和 OAR 的剂量/体积限制的计划方案。4/5f IMRT 显示出最大的适形度和均匀性。与 3D-CRT 相比,2/3f(p=0.01)和 4/5f(p=0.0009)的 IMRT 可显著降低股骨 V45。4/5f IMRT 可显著降低正常组织 V55(p=0.004)和最大剂量(p=0.04),与 3D-CRT 相比。

结论

制定了一套可重复的 3D-CRT 和 IMRT 计划指南和剂量-体积限制。4/5f IMRT 联合 SIB 可更好地覆盖靶区,同时显著降低 OAR 剂量。建议在临床试验中进一步评估该技术,以证明更复杂技术的技术优势转化为患者受益,从而降低晚期毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验